AI assistant
STANDARD BIOTOOLS INC. — Director's Dealing 2025
Apr 8, 2025
32853_dirs_2025-04-08_3680031d-4a38-47c2-a788-e5d03b2cfabd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2025-04-04
Reporting Person: Kim Hanjoon Alex (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-04-04 | Common Stock | M | 70183 | — | Acquired | 962281 | Direct |
| 2025-04-04 | Common Stock | F | 21441 | $1.07 | Disposed | 940840 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-04-04 | Restricted Stock Units | $ | M | 70183 | Disposed | Common Stock (70183) | Direct |
Footnotes
F1: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units ("RSUs") granted to the reporting person on April 4, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on April 6, 2022.
F2: Each RSU represents the contingent right to receive one share of the Issuer's common stock.
F3: On April 4, 2022, the Reporting Person was granted 280,732 RSUs, vesting in four equal annual installments beginning on April 4, 2023.